Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
KAHR medical
company
About
KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $3M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2005
- Number Of Employee
- 1 - 10
- Operating Status
- Active
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment options for cancer and autoimmune disorders.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$67.50M
KAHR medical has raised a total of
$67.50M
in funding over 2 rounds. Their latest funding was raised on
Jun 16, 2021 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 16, 2021 | Series Unknown | $46.50M | 1 | — | — | Detail |
| Feb 25, 2020 | Series Unknown | $18M | 1 | — | — | Detail |
| Apr 14, 2011 | Series Unknown | $3M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
KAHR medical is funded by 2 investors.
Pavilion Capital
and Sanofi
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Pavilion Capital
|
— | Series Unknown |
Sanofi
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
